Kyntra Bio Inc Sustainability Reports
Kyntra Bio, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies for oncology and rare diseases. Its pipeline includes antibody-drug conjugates and treatments for anemia associated with myelodysplastic syndromes.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300Q914ULWWY95822
8 reports from 2015 to 2025
Company Profile
Kyntra Bio, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies for oncology and rare diseases. Its pipeline includes antibody-drug conjugates and treatments for anemia associated with myelodysplastic syndromes.
Reports
8 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
